Intellectual Property

Intellectual property disputes take place on a daily basis in a variety of venues. From an employee’s right to a patent of company-developed products to patent wars between international companies for illegal use of a product/logo, the National Law Review is a great resource for updates on all things IP. The site covers litigation at the United States Patent and Trademark Office (USPTO) and the  Patent Trial and Board Appeals (PTAB), as well as cases in front of the International Trade Commission (ITC) for international patent disputes. The National Law Review covers cases heard by the Supreme Court of the United States (SCOTUS), or appeals which are now sitting in front of the patent-board on Inter partes review (IPR). Additionally, the National Law Review covers cases and decisions of the Federal Trade Commission (FTC).

Copyrights, patent infringement claims, trade secrets, false advertising claims, unfair competition, and intellectual property laws which govern patent-litigation, are all areas which the National Law Review covers, in detail for readers. Patent disputes don’t only occur in the United States. When international countries including the United Kingdom, Brazil, China, India, and the European Union get involved, international laws are also taken into consideration by the PTO. Additionally, information on how to obtain patent protection internationally is also available on the National Law Review.

Intellectual property news on the National Law Review spans from topics including biosimilars, domain name registration, generic top-level domains (gTLDs), drug patents, non-compete agreements, trade secrets, and other industry-related battles which ensue, are covered on the site. Visitors can read about the latest legislation, laws, and news, as it relates to patents and intellectual property in general. Further, visitors to the National Law Review are going to find the latest stories and litigation as it unfolds in front of patent courts across the land. From email and data retention policies, patent disputes over medical devices, cloud computing and artificial intelligence the National Law Review has the details and expert intellectual property litigation legal analysis readers count on.

For hourly updates on the latest news about Intellectual Property Law, IP Litigation, Patent Legislation, and more, be sure to follow our IP Law Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization Sort descending
Mar
27
2014
Protecting and Enforcing Trade Secrets in China Michael Best & Friedrich LLP
Apr
2
2014
Divisional Practice in the BRICs and other Countries – Part 9 of a 9-Part Series: A Comprehensive Summary Michael Best & Friedrich LLP
Jul
8
2014
Patent Troll Update: Brazil Michael Best & Friedrich LLP
Sep
5
2014
Update: The Thorny Problem of Patentable Eligible Subject Matter: Part 8 of a 10-Part Series: Australia Michael Best & Friedrich LLP
Mar
23
2017
U.S. Supreme Court Rules on Copyright Protection for Cheerleader Uniform Michael Best & Friedrich LLP
Nov
20
2014
A Report from the “Biosimilars and Biotech: MENA Conference” in Istanbul, Turkey: Part 1 Michael Best & Friedrich LLP
Jan
5
2015
Be Mindful of Your Claims in Divisional Applications and Patents in South Africa Michael Best & Friedrich LLP
Mar
13
2015
At the Board: Post Grant Proceedings at the PTAB Michael Best & Friedrich LLP
Jul
27
2010
Prior Art Date for Patent Can Go Back to Provisional Filing Date Michael Best & Friedrich LLP
Nov
5
2010
Supreme Court to Review Whether University Owns Patent Under Bayh-Dole Act Michael Best & Friedrich LLP
Mar
1
2011
A Federal District Court Rules That The Qui Tam Provision of the False Marking Statute is Unconstitutional Michael Best & Friedrich LLP
Sep
27
2011
USPTO Announces Effective Dates of America Invents Act Michael Best & Friedrich LLP
Jun
7
2015
Federal Circuit Hears Oral Arguments in Litigation involving the First U.S. Biosimilar Product Michael Best & Friedrich LLP
Aug
3
2015
In Mexico: Can the Minimum Period of 5 Years Established by NAFTA for Regulatory Data Exclusivity be Extended for Biological Medical Products? Michael Best & Friedrich LLP
Jan
24
2013
What to Consider Now Regarding the March 16, 2013 Patent Law Change Michael Best & Friedrich LLP
Oct
28
2015
Brazil: Federal District Court in Rio de Janeiro Declares AstraZeneca’s Patent Covering Fosladex Invalid Michael Best & Friedrich LLP
Dec
11
2015
Role of Previously Considered Prior Art in Deciding to Institute Inter Partes Review Michael Best & Friedrich LLP
Jun
13
2013
U.S. Supreme Court Rules that Isolated Human Genes Are Not Patentable Michael Best & Friedrich LLP
Jul
12
2013
New Russian Intellectual Property Court is Open Michael Best & Friedrich LLP
Oct
4
2013
Federal Government Shutdown - U.S. Patent and Trademark Office (USPTO) to Temporarily Continue Operations Michael Best & Friedrich LLP
Oct
16
2013
Recent Brazilian Jurisprudence Concerning the Scope of the National Sanitary Vigilance Agency’s (ANVISA) Prior Consent Michael Best & Friedrich LLP
Mar
29
2016
Expediting Patent Prosecution in Brazil Michael Best & Friedrich LLP
May
16
2016
Indian Patent Office's Patent to Gilead’s Sovaldi Challenged at Delhi High Court Michael Best & Friedrich LLP
May
11
2014
The Thorny Problem of Patentable Eligible Subject Matter: Part 2 of a 10-Part Series: Canada Michael Best & Friedrich LLP
May
16
2014
Lawmakers Advocate for Common Cheese Names Michael Best & Friedrich LLP
Jul
6
2016
Federal Circuit Rules Biosimilar Notice of Commercial Marketing Mandatory Michael Best & Friedrich LLP
Oct
3
2016
Ukraine’s Competition Authority Issues Major Decision on Drug Pricing Practices Michael Best & Friedrich LLP
Aug
18
2014
The Thorny Problem of Patentable Eligible Subject Matter: Part 7 of a 10-Part Series: China Michael Best & Friedrich LLP
Sep
11
2014
The Thorny Problem of Patentable Eligible Subject Matter: Part 9 of a 10-Part Series: South Africa Michael Best & Friedrich LLP
Oct
27
2014
A Review of the Status of Biosimilars in the U.S. Michael Best & Friedrich LLP
May
26
2017
Widespread Use of GOOGLE Trademark as a Verb Does Not Render the Mark Generic Michael Best & Friedrich LLP
Nov
28
2014
Brazil: An Update of the Most Relevant Events for Pharmaceutical Companies in 2014: Part 3 of a 5-Part Series Michael Best & Friedrich LLP
Mar
2
2011
Section 145 Action to Obtain a Patent Michael Best & Friedrich LLP
Apr
8
2011
United States Patent Reform Act Michael Best & Friedrich LLP
Sep
5
2017
Federal Circuit Rejects PTAB’s Articulation of Obviousness Rationale, Disregard for Evidence, and Burden Shifting Michael Best & Friedrich LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins